Precision BioSciences to Report Fourth Quarter and Fiscal Year 2021 Results on March 15, 2022Business Wire • 03/08/22
Precision BioSciences (DTIL) Stock Sinks As Market Gains: What You Should KnowZacks Investment Research • 02/17/22
Precision BioSciences (DTIL) Gains But Lags Market: What You Should KnowZacks Investment Research • 02/09/22
Precision BioSciences to Present at the 40th Annual J.P. Morgan Health Care ConferenceBusiness Wire • 01/04/22
Precision BioSciences Reports Clinical Program Updates for Its Allogeneic CAR T PipelineBusiness Wire • 12/11/21
Precision BioSciences to Host Virtual Webcast and Conference Call to Review Interim Phase 1/2a PBCAR0191 CAR T Data and Provide CAR T Program Updates on Saturday, December 11, 2021Business Wire • 12/06/21
Precision BioSciences to Present Preclinical Gene Editing Data on its ARCUS-Based Chronic Hepatitis B Program at the HEP DART 2021 ConferenceBusiness Wire • 12/03/21
Wall Street Analysts See a 98% Upside in Precision BioSciences (DTIL): Can the Stock Really Move This High?Zacks Investment Research • 11/15/21
Precision BioSciences Reports Third Quarter 2021 Financial Results and Provides Business UpdateBusiness Wire • 11/10/21
Precision BioSciences to Highlight Capabilities of ARCUS Gene Editing for Allogeneic CAR T Cell Immunotherapies at The Society for Immunotherapy of Cancer 36th Annual MeetingBusiness Wire • 11/09/21
Precision BioSciences Appoints Sam Wadsworth, Ph.D. and Shari Lisa Piré, J.D.Business Wire • 11/08/21
Precision BioSciences Announces Two Oral Presentations Highlighting Updated Interim Data from Lead PBCAR0191 CAR T Immunotherapy for Relapsed and Refractory B-cell Malignancies at the 63rd Annual Meeting of the American Society of HematologyBusiness Wire • 11/04/21
Precision BioSciences to Report Third Quarter 2021 Financial Results on November 10, 2021 and Participate in the Stifel 2021 Virtual Healthcare Conference on November 16, 2021Business Wire • 11/03/21
Analysts Estimate Precision BioSciences (DTIL) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 11/02/21
Precision BioSciences to Present at the Jefferies Virtual Gene Therapy/Editing Summit on Thursday, October 27, 2021Business Wire • 10/21/21
Precision BioSciences Announces Grant of Inducement Award for Newly Appointed Chief Executive Officer Pursuant to Nasdaq Listing Rule 5635(c)(4)Business Wire • 09/27/21
Precision BioSciences to Present at H.C. Wainwright 23rd Annual Global Investment ConferenceBusiness Wire • 09/10/21
Precision BioSciences Outlines Clinical Development Strategy for In Vivo Gene Editing PipelineBusiness Wire • 09/09/21
Precision BioSciences and iECURE Announce License and Collaboration Agreement to Develop ARCUS-Based Gene Editing TherapiesBusiness Wire • 09/09/21